Verastem Presents Avutometinib and Defactinib Combination Pr

Verastem Presents Avutometinib and Defactinib Combination Program Updates at the 5th Annual RAS-Targeted Drug Development Summit

Verastem Presents Avutometinib and Defactinib Combination Program Updates at the 5th Annual RAS-Targeted Drug Development Summit

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Massachusetts , United States , London , City Of , United Kingdom , Boston , American , Louis Denis , Dan Paterson , Elisa Buffington , Ryan Porter , Dan Calkins , Udai Banerji , Jonathan Pachter , Nasdaq , Drug Development Summit , Drug Administration , American Society Of Clinical Oncology , Corporate Communications , Amgen , Institute Of Cancer Research , Drug Development Unit , Raf And Mek Program , Clinical Presentations Include Update , Low Grade Serous Ovarian Cancer Efficacy , Targeted Drug Development Summit , Chief Scientific Officer , Chief Medical Officer , Enhancing Antitumor Efficacy , Rational Combinations , Breakthrough Therapy Designation , Chief Executive Officer , Professor Udai Banerji , Deputy Director , Cancer Research , Royal Marsden , American Society , Clinical Oncology , Breakthrough Therapy , Verastem Oncology ,